CytomX Therapeutics, Inc. (CTMX)

CytomX Therapeutics, Inc. (CTMX) is a healthcare company (biotechnology) based in the United States. The share price is $1.98, down 0.50% on the day, which values the company at $430.56M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$1.98−0.50% today
Market value
$430.56M
Funk Score
40/100
200-week average
$2.2312% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

CytomX Therapeutics, Inc. in more detail

CTMX trades at -4.0× next year's expected earnings, 30.7× sales. It sits 12% below its 200-week average of $2.23.

Over the last five fiscal years CytomX Therapeutics, Inc. has compounded revenue 2.2% a year. Its Funk Score is 40 out of 100 (financial strength 4.2, profitability 2.8, growth 5.0, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

1 of the superinvestors tracked here hold CTMX, including Julian and Felix Baker (0.1% of the portfolio).

Superinvestors holding CTMX

1 of the investors tracked here report a position in their latest 13F filing.

CytomX Therapeutics, Inc. (CTMX): questions and answers

What is CytomX Therapeutics, Inc.'s market cap?

CytomX Therapeutics, Inc. is valued at $430.56M at a share price of $1.98.

Is CTMX above its 200-week moving average?

No. CTMX is 11.5% below its 200-week average of $2.23. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is CytomX Therapeutics, Inc. growing?

Over the last five fiscal years CytomX Therapeutics, Inc.'s revenue grew 2.2% a year; over ten years revenue grew 25.7% a year.

Does CTMX pay a dividend?

CytomX Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own CTMX?

In their latest quarterly filings, Julian and Felix Baker (0.1% of the portfolio) hold CTMX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “CytomX Therapeutics, Inc. (CTMX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/CTMX

Underlying data: Yahoo Finance; company filings with the SEC.